Yntesty- bacteriophage | Intesti-bacteriophage liquid bottles, 100 ml
Special Price
$30.38
Regular Price
$38.00
In stock
SKU
BID461802
Release form
Solution for oral administration or rectal administration.
Solution for oral administration or rectal administration.
Release form
Solution for oral administration or rectal administration.
Packing
Bottle 100 ml.
Pharmacological action
drug causes specific lysis of bacteria Shigella flexneri 1, 2, 3, 4, 6 serovariantami, Shigella sonnei, Salmonella paratyphi A, Salmonella paratyphi B, Salmonella typhymurium, Salmonella infantis, Salmonella choleraesuis, Salmonella oranienburg, Salmonella enteritidis, Escherichia coli, Proteus vulgaris, Proteus mirabilis, Enterococcus, Staphylococcus, Pseudomonas aeruginosa.
Salmonellosis.
Dyspepsia.
Dysbacteriosis.
Enterocolitis, pricks.
An important condition for effective phage therapy is a preliminary determination of the phage sensitivity of the pathogen.
Contraindications
Hypersensitivity to the components of the drug.
Use during pregnancy and lactation
Use of this medicine during pregnancy and during lactation is possible in the presence of infections caused by phagosensitive bacteria strains (as recommended by a doctor).
Special instructions
Do not use if cloudy!
Due to the presence in the preparation of a nutrient medium in which bacteria from the environment can develop, causing clouding of the drug, the following rules must be observed when opening the bottle:
Wash hands thoroughly.
Treat the cap with an alcohol-containing solution.
Remove the cap without opening the plug.
Do not place the cork with the inner surface on a table or other objects.
Do not leave vial open.
Store the opened bottle only in the refrigerator.
When using small doses (2-8 drops), the drug must be selected with a sterile syringe in a volume of 0.5-1 ml.
The drug from an opened bottle, subject to storage conditions, the above rules and the absence of turbidity, can be used throughout the expiration date.
Effect of the drug on the ability to drive vehicles,
mechanisms None.
Composition
solution comprises:
Actives: ethyl sterile filtrates fagolizatov Shigella flexneri 1, 2, 3, 4, and 6 serovars, Shigella sonnei, Salmonella paratyphi A, Salmonella paratyphi B, Salmonella typhimurium, Salmonella infantis, Salmonella choleraesuis, Salmonella oranienburg , Salmonella enteritidis, enteropathogenic Escherichia coli of various serogroups, the most significant in the etiology of enteric diseases, Proteus vulgaris, Proteus mirabilis, Enterococcus, Staphylococcus, Pseudomonas aeruginosa.
aux a mixture of sterile filtrates of Shigella flexneri 1, 2, 3, 4, 6 serovars phagolysates, Shigella sonnei, Salmonella paratyphi A, Salmonella paratyphi B, Salmonella typhimurium, Salmonella infantis, Salmonella choleraesuis, Salmonella oranienburg, Salmonella enteritidi ericerich, significant in the etiology of enteric diseases, Proteus vulgaris, Proteus mirabilis, Enterococcus, Staphylococcus, Pseudomonas aeruginosa.
aux a mixture of sterile filtrates of Shigella flexneri 1, 2, 3, 4, 6 serovars phagolysates, Shigella sonnei, Salmonella paratyphi A, Salmonella paratyphi B, Salmonella typhimurium, Salmonella infantis, Salmonella choleraesuis, Salmonella oranienburg, Salmonella enteritidi ericerich, significant in the etiology of enteric diseases, Proteus vulgaris, Proteus mirabilis, Enterococcus, Staphylococcus, Pseudomonas aeruginosa.
auxnutrients: quinozole 0.0001 g / ml.
Dosage and administration
The drug is intended for oral administration and rectal administration. For treatment, the drug is taken orally 4 times a day for 0.5-1 hours before a meal from the first day of the disease for 7-10 days.
Children in the first months of life in the first two days of taking the drug are diluted with boiled water twice, in the absence of adverse reactions (regurgitation, rashes on the skin) in the future, you can use undiluted bacteriophage. The drug is administered by mouth 3 times a day 30 minutes before feeding. In cases of indomitable vomiting, the drug is used in the form of high enemas (through a gas tube or catheter) daily. Perhaps a combination of rectal (in the form of high enemas) and oral administration of the drug. The course of treatment is 7-10 days.
Recommended dosage:
Age 0-6 months. - 5 ml (dose for 1 dose orally) - 10 ml (dose for 1 dose rectally).
Age 6-12 months - 10-15 (dose for 1 dose orally) - 20 (dose for 1 dose rectally).
Age from 1 year to 3 years - 15-20 (dose per 1 dose orally) - 20-30 (dose per 1 dose rectally).
Age from 3 to 8 years - 20-30 (dose per oral dose) - 30-40 (dose per rectal dose).
Age of 8 years and older - 30-40 (dose per oral dose) - 50-60 (dose per rectal dose).
In the absence of a colitic syndrome, it is recommended to replace one ingestion with a single rectal administration of a single age-related dose of the drug in the form of an enema after bowel movement.
For preventive purposes, the optimal regimen is a daily dose of a single age-related dose. The duration of the drug is determined by the conditions of the epidemiological situation.
Side effects of
In children of the first months of life, regurgitation, rashes on the skin are possible in the first 2 days of taking the drug.
Drug interactions
The use of the drug is possible in combination with other drugs, including with antibiotics.
Overdose
Overdose symptoms have not been established.
Storage Conditions
Store in accordance with SP 3.3.2.1248-03 in a dry, dark place and out of the reach of children at 2 to 8 РC.
Transport in accordance with SP 3.3.2.1248-03 at 2 to 8 РC. It is allowed to transport at a temperature of 8 to 25 РC for no more than 1 month.
Shelf life
2 years.
Active substance
Bacteriophage intestine
Terms and conditions
prescription
dosage form
oral solution
Possible product names
Bacteriophage Intesti 100ml
BACTERIOFAG-INTESTI RR INTERNAL / REKT 100ML
Intesti Bacteriophage 100ml Fl. BM M
INTESTI-BACTERIOPHAGE 100ML
INTESTI-BACTERIOPHAGE 100ML. FL
Microgen NPO, Russia
Solution for oral administration or rectal administration.
Packing
Bottle 100 ml.
Pharmacological action
drug causes specific lysis of bacteria Shigella flexneri 1, 2, 3, 4, 6 serovariantami, Shigella sonnei, Salmonella paratyphi A, Salmonella paratyphi B, Salmonella typhymurium, Salmonella infantis, Salmonella choleraesuis, Salmonella oranienburg, Salmonella enteritidis, Escherichia coli, Proteus vulgaris, Proteus mirabilis, Enterococcus, Staphylococcus, Pseudomonas aeruginosa.
Salmonellosis.
Dyspepsia.
Dysbacteriosis.
Enterocolitis, pricks.
An important condition for effective phage therapy is a preliminary determination of the phage sensitivity of the pathogen.
Contraindications
Hypersensitivity to the components of the drug.
Use during pregnancy and lactation
Use of this medicine during pregnancy and during lactation is possible in the presence of infections caused by phagosensitive bacteria strains (as recommended by a doctor).
Special instructions
Do not use if cloudy!
Due to the presence in the preparation of a nutrient medium in which bacteria from the environment can develop, causing clouding of the drug, the following rules must be observed when opening the bottle:
Wash hands thoroughly.
Treat the cap with an alcohol-containing solution.
Remove the cap without opening the plug.
Do not place the cork with the inner surface on a table or other objects.
Do not leave vial open.
Store the opened bottle only in the refrigerator.
When using small doses (2-8 drops), the drug must be selected with a sterile syringe in a volume of 0.5-1 ml.
The drug from an opened bottle, subject to storage conditions, the above rules and the absence of turbidity, can be used throughout the expiration date.
Effect of the drug on the ability to drive vehicles,
mechanisms None.
Composition
solution comprises:
Actives: ethyl sterile filtrates fagolizatov Shigella flexneri 1, 2, 3, 4, and 6 serovars, Shigella sonnei, Salmonella paratyphi A, Salmonella paratyphi B, Salmonella typhimurium, Salmonella infantis, Salmonella choleraesuis, Salmonella oranienburg , Salmonella enteritidis, enteropathogenic Escherichia coli of various serogroups, the most significant in the etiology of enteric diseases, Proteus vulgaris, Proteus mirabilis, Enterococcus, Staphylococcus, Pseudomonas aeruginosa.
aux a mixture of sterile filtrates of Shigella flexneri 1, 2, 3, 4, 6 serovars phagolysates, Shigella sonnei, Salmonella paratyphi A, Salmonella paratyphi B, Salmonella typhimurium, Salmonella infantis, Salmonella choleraesuis, Salmonella oranienburg, Salmonella enteritidi ericerich, significant in the etiology of enteric diseases, Proteus vulgaris, Proteus mirabilis, Enterococcus, Staphylococcus, Pseudomonas aeruginosa.
aux a mixture of sterile filtrates of Shigella flexneri 1, 2, 3, 4, 6 serovars phagolysates, Shigella sonnei, Salmonella paratyphi A, Salmonella paratyphi B, Salmonella typhimurium, Salmonella infantis, Salmonella choleraesuis, Salmonella oranienburg, Salmonella enteritidi ericerich, significant in the etiology of enteric diseases, Proteus vulgaris, Proteus mirabilis, Enterococcus, Staphylococcus, Pseudomonas aeruginosa.
auxnutrients: quinozole 0.0001 g / ml.
Dosage and administration
The drug is intended for oral administration and rectal administration. For treatment, the drug is taken orally 4 times a day for 0.5-1 hours before a meal from the first day of the disease for 7-10 days.
Children in the first months of life in the first two days of taking the drug are diluted with boiled water twice, in the absence of adverse reactions (regurgitation, rashes on the skin) in the future, you can use undiluted bacteriophage. The drug is administered by mouth 3 times a day 30 minutes before feeding. In cases of indomitable vomiting, the drug is used in the form of high enemas (through a gas tube or catheter) daily. Perhaps a combination of rectal (in the form of high enemas) and oral administration of the drug. The course of treatment is 7-10 days.
Recommended dosage:
Age 0-6 months. - 5 ml (dose for 1 dose orally) - 10 ml (dose for 1 dose rectally).
Age 6-12 months - 10-15 (dose for 1 dose orally) - 20 (dose for 1 dose rectally).
Age from 1 year to 3 years - 15-20 (dose per 1 dose orally) - 20-30 (dose per 1 dose rectally).
Age from 3 to 8 years - 20-30 (dose per oral dose) - 30-40 (dose per rectal dose).
Age of 8 years and older - 30-40 (dose per oral dose) - 50-60 (dose per rectal dose).
In the absence of a colitic syndrome, it is recommended to replace one ingestion with a single rectal administration of a single age-related dose of the drug in the form of an enema after bowel movement.
For preventive purposes, the optimal regimen is a daily dose of a single age-related dose. The duration of the drug is determined by the conditions of the epidemiological situation.
Side effects of
In children of the first months of life, regurgitation, rashes on the skin are possible in the first 2 days of taking the drug.
Drug interactions
The use of the drug is possible in combination with other drugs, including with antibiotics.
Overdose
Overdose symptoms have not been established.
Storage Conditions
Store in accordance with SP 3.3.2.1248-03 in a dry, dark place and out of the reach of children at 2 to 8 РC.
Transport in accordance with SP 3.3.2.1248-03 at 2 to 8 РC. It is allowed to transport at a temperature of 8 to 25 РC for no more than 1 month.
Shelf life
2 years.
Active substance
Bacteriophage intestine
Terms and conditions
prescription
dosage form
oral solution
Possible product names
Bacteriophage Intesti 100ml
BACTERIOFAG-INTESTI RR INTERNAL / REKT 100ML
Intesti Bacteriophage 100ml Fl. BM M
INTESTI-BACTERIOPHAGE 100ML
INTESTI-BACTERIOPHAGE 100ML. FL
Microgen NPO, Russia
Write Your Own Review